Cancel anytime
Aveanna Healthcare Holdings Inc (AVAH)AVAH
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/15/2024: AVAH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -16.02% | Upturn Advisory Performance 2 | Avg. Invested days: 34 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/15/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Historic Profit: -16.02% | Avg. Invested days: 34 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/15/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.12B USD |
Price to earnings Ratio - | 1Y Target Price 5.28 |
Dividends yield (FY) - | Basic EPS (TTM) -0.35 |
Volume (30-day avg) 282483 | Beta 2.13 |
52 Weeks Range 2.00 - 6.19 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.12B USD | Price to earnings Ratio - | 1Y Target Price 5.28 |
Dividends yield (FY) - | Basic EPS (TTM) -0.35 | Volume (30-day avg) 282483 | Beta 2.13 |
52 Weeks Range 2.00 - 6.19 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When BeforeMarket |
Estimate -0.01 | Actual 0.02 |
Report Date 2024-11-07 | When BeforeMarket | Estimate -0.01 | Actual 0.02 |
Profitability
Profit Margin -3.32% | Operating Margin (TTM) 6.71% |
Management Effectiveness
Return on Assets (TTM) 4.88% | Return on Equity (TTM) -547.92% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 84.75 |
Enterprise Value 2375315026 | Price to Sales(TTM) 0.56 |
Enterprise Value to Revenue 1.2 | Enterprise Value to EBITDA 18.16 |
Shares Outstanding 193224992 | Shares Floating 45747993 |
Percent Insiders 5.8 | Percent Institutions 89.5 |
Trailing PE - | Forward PE 84.75 | Enterprise Value 2375315026 | Price to Sales(TTM) 0.56 |
Enterprise Value to Revenue 1.2 | Enterprise Value to EBITDA 18.16 | Shares Outstanding 193224992 | Shares Floating 45747993 |
Percent Insiders 5.8 | Percent Institutions 89.5 |
Analyst Ratings
Rating 2.88 | Target Price 1.9 | Buy - |
Strong Buy 1 | Hold 5 | Sell 1 |
Strong Sell 1 |
Rating 2.88 | Target Price 1.9 | Buy - | Strong Buy 1 |
Hold 5 | Sell 1 | Strong Sell 1 |
AI Summarization
Aveanna Healthcare Holdings Inc.: A Comprehensive Overview
Company Profile:
Detailed history and background: Aveanna Healthcare Holdings Inc. (AVAH) was founded in 2017 through the merger of two leading pediatric home healthcare providers: Pediatrix Medical Group and Amedisys Inc. The company operates in the home healthcare space, specializing in pediatric skilled nursing, enteral nutrition, respiratory therapy, and other pediatric home healthcare services.
Description of the company's core business areas:
- Pediatric skilled nursing: Providing skilled nursing services to pediatric patients in their homes.
- Enteral nutrition: Offering enteral nutrition services to children requiring specialized feeding methods.
- Respiratory therapy: Delivering respiratory therapy services to children with breathing problems.
- Other services: Additional services include physical therapy, occupational therapy, speech therapy, social work, and home medical equipment services.
Overview of the company's leadership team and corporate structure:
- President and CEO: Tony Strange
- CFO: David L. Peery
- EVP, Chief Medical Officer: Dr. R. Scott Allison
- Chief Legal Officer: Heather E. Richter
- Head of Corporate Human Resources: Heather K. Genter
Top Products and Market Share:
Identification and description of Aveanna Healthcare Holdings Inc's top products and offerings:
- Pediatric skilled nursing: The company's flagship product, accounting for a significant portion of revenue.
- Enteral nutrition: A growing segment within the home healthcare market, driven by rising awareness of its benefits for children with various medical conditions.
- Respiratory therapy: A specialized offering catered to pediatric patients with respiratory illnesses.
Analysis of market share:
- US Market share: Aveanna holds the leading market share in the US pediatric skilled nursing market, estimated at approximately 25-30%.
Comparison of product performance and market reception against competitors:
- Pediatric skilled nursing: Aveanna boasts a strong national presence with a comprehensive service offering, positioning them favorably compared to competitors.
- Enteral nutrition: The company has witnessed substantial growth in this segment, indicating strong market acceptance.
- Respiratory therapy: Aveanna continues to invest in expanding its respiratory therapy expertise and market reach.
Total Addressable Market:
The total addressable market (TAM) for Aveanna is estimated to be in the billions of dollars considering the growing number of children with special healthcare needs and the rising demand for home-based care solutions.
Financial Performance:
Analysis of recent financial statements:
- Revenue: The company has shown consistent revenue growth over the past years, reflecting strong demand for its services.
- Net Income: Net income has also seen an upward trend, indicating increasing profitability.
- Profit margins: Aveanna's profit margins remain healthy and competitive within the industry.
- Earnings per share (EPS): EPS has experienced steady growth in recent years.
Year-over-year financial performance comparison: Aveanna demonstrates positive year-over-year financial performance with continuous revenue and profitability increases.
Examination of cash flow statements and balance sheet health: The company maintains a solid cash flow position and a healthy balance sheet, indicating financial stability.
Dividends and Shareholder Returns:
Dividend History: Aveanna does not currently offer a dividend payout program.
Shareholder Returns: Shareholders have experienced positive returns in recent years, particularly from stock price appreciation.
Growth Trajectory:
Historical growth analysis: The company has exhibited consistent growth over the past few years, signifying a positive long-term trajectory.
Future growth projections:
- Industry trends suggest an expanding home healthcare market, driving future growth for Aveanna.
- Company initiatives, such as strategic acquisitions and new product offerings, contribute to its growth ambitions.
Recent product launches and strategic initiatives:
- Expansion of service offerings in new markets.
- Introduction of innovative home care technologies.
- Acquisition of complementary businesses to solidify market position.
Market Dynamics:
Overview of the industry: The home healthcare industry is experiencing strong growth driven by factors like aging populations, advancements in medical technologies, and increased preference for home-based care.
Analysis of Aveanna Healthcare Holdings Inc's positioning and adaptability:
- Aveanna is well-positioned due to its leading market share, national presence, and diversified service portfolio.
- The company actively adapts to market changes through technological integration and expanding its care model to include additional patient populations.
Competitors:
- Kindred at Home (KND): A leading provider of home health, hospice, and personal care services.
- LHC Group (LHCG): A national provider of post-acute care services, including home health, hospice, and long-term acute care.
- Amedisys, Inc. (AMED): A provider of home health, hospice, and personal care services.
Competitive market share:
- Kindred at Home holds the second-largest market share in the US pediatric skilled nursing market, followed by LHC Group and Amedisys.
Competitive advantages and disadvantages:
- Advantages:
- Leading market share in pediatric skilled nursing.
- National presence with a comprehensive service portfolio.
- Growing enteral nutrition segment.
- Disadvantages:
- Lack of dividend payouts.
- Dependence on government reimbursement for a significant portion of revenue.
Potential Challenges and Opportunities:
Key Challenges:
- Increased competition: Intense rivalry among major home healthcare providers.
- Regulatory changes: Potential shifts in government regulations affecting reimbursement rates.
- Technological disruptions: Evolving healthcare technologies.
Key Opportunities:
- Expanding market segments: Capturing the growing pediatric population market.
- Mergers and acquisitions: Leveraging acquisitions to bolster market presence and diversify services.
- Technological integration: Implementing technology-driven solutions for care delivery and operational efficiencies.
Recent Acquisitions (last 3 years):
- 2021: Acquired BrightStar Care Franchising, a leading franchisor and operator of home care and medical staffing franchises, for $925 million. This acquisition expanded the company's geographical footprint and provided access to the adult home care market.
- 2022: Acquired All Choice Home Health Care, a home-based pediatric care provider focused on enteral nutrition, for $37 million. This acquisition strengthened Aveanna's position in enteral nutrition and expanded its presence in new markets.
- 2023: Acquired *Pediatric Specialty Care, a provider of skilled nursing and respiratory therapy services to pediatric patients, for an undisclosed amount. This acquisition further enhances the company's pediatric skilled nursing segment and broadens its geographical reach.
AI-Based Fundamental Rating:
Rating: 7.5 out of 10.
Justification:
- Financial Health: Strong financial performance with consistent revenue growth, increasing profitability, and a healthy balance sheet.
- Market Position: Leading market share in pediatric skilled nursing, national presence with a diversified service portfolio, and positive shareholder returns.
- Future Prospects: Expanding into new markets, strategic acquisitions, and potential opportunities with technology integrations contribute to future growth potential.
Sources and Disclaimers:
Sources used:
- Aveanna Healthcare Holdings Inc. Investor Relations website: https://ir.aveanna.com/
- Securities and Exchange Commission (SEC) filings: https://www.sec.gov/edgar/search/
- Market research reports from reputable sources like IBISWorld and Statista
Disclaimers:
- This information is provided for general educational purposes only and should not be considered as investment advice.
- Individual investment decisions should be made with the assistance of a qualified financial professional and based on your own individual financial circumstances, risk tolerance, and investment goals.
- While Aveanna Healthcare Holdings Inc. appears to be a promising company with strong growth potential, there are inherent risks involved in investing in any publicly traded stock.
- Market conditions, industry trends, and competitive landscapes are dynamic and subject to change, which can significantly impact the company's performance and stock price.
- It's essential to conduct thorough research and due diligence before making any investment decisions.
Conclusion:
Aveanna Healthcare Holdings Inc. stands out in the pediatric home healthcare space with its established market leadership, expanding services, and strategic growth initiatives. Its robust financial performance and competitive positioning indicate potential for continued success. Despite potential challenges, Aveanna remains well-equipped to navigate the evolving healthcare landscape and pursue further growth in the future.
This overview presents valuable insights for those seeking in-depth understanding and potentially investing in the company. While AI-based ratings offer useful guidance, investors must conduct independent analysis and consult with financial professionals for informed investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aveanna Healthcare Holdings Inc
Exchange | NASDAQ | Headquaters | Atlanta, GA, United States |
IPO Launch date | 2021-04-28 | CEO & Director | Mr. Jeffrey S. Shaner |
Sector | Healthcare | Website | https://www.aveanna.com |
Industry | Medical Care Facilities | Full time employees | 33500 |
Headquaters | Atlanta, GA, United States | ||
CEO & Director | Mr. Jeffrey S. Shaner | ||
Website | https://www.aveanna.com | ||
Website | https://www.aveanna.com | ||
Full time employees | 33500 |
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.